Valuation: Kuros Biosciences AG

Market Cap 807M 978M 874M 731M 1.37B 92.87B 1.39B 9.71B 3.85B 48.66B 3.67B 3.59B 153B P/E 2026 *
88.6x
P/E 2027 * 43.6x
Enterprise Value 801M 971M 867M 726M 1.36B 92.15B 1.38B 9.64B 3.82B 48.28B 3.64B 3.57B 152B EV / Sales 2026 *
4.71x
EV / Sales 2027 * 3.56x
Free-Float
65.72%
Yield 2026 *
-
Yield 2027 * -
1 day-0.29%
1 week+20.83%
Current month+10.99%
1 month+18.16%
3 months+2.53%
6 months-7.89%
Current year-26.13%
1 week 16.52
Extreme 16.52
20.88
1 month 16.52
Extreme 16.52
20.88
Current year 16.46
Extreme 16.46
30.3
1 year 16.46
Extreme 16.46
32.48
3 years 2.46
Extreme 2.46
34.2
5 years 1.11
Extreme 1.11
34.2
10 years 1.11
Extreme 1.11
34.2
Manager TitleAgeSince
Chief Executive Officer 56 2023-10-11
Chief Executive Officer 60 2017-12-03
Director of Finance/CFO - 2023-02-16
Director TitleAgeSince
Chairman 69 2018-06-13
Director/Board Member 60 2018-06-13
Director/Board Member 57 2018-06-13
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/26 Sell -7,225 0.0184%
12/13/25 Sell 30,000 0.0766%
12/8/25 Sell 30,000 0.0766%
Change 5-day change 1-year change 3-year change Capi.($)
-0.29%+20.83%-31.88%+712.00% 978M
+2.41%+0.29%+39.41%+72.14% 64.69B
-0.15%+7.50%+11.42%+71.27% 54.78B
+0.57%+4.60%+7.71%+90.93% 53.49B
+0.37%+4.67%+26.68%+49.64% 45.98B
-1.21%+2.32%+21.50%+118.33% 42.94B
-0.37%+5.07%+243.23%+789.58% 40.08B
+0.05%+0.21%+18.06%+48.50% 33.52B
+1.19%-4.98%+26.31%-0.76% 23.97B
-0.38%+5.68%+38.39%+28.35% 23.67B
Average +0.22%+4.26%+40.08%+198.00% 38.41B
Weighted average by Cap. +0.39%+2.78%+45.82%+144.29%

Financials

2026 *2027 *
Net sales 170M 206M 184M 154M 288M 19.56B 293M 2.05B 810M 10.25B 773M 757M 32.32B 220M 267M 238M 199M 373M 25.32B 379M 2.65B 1.05B 13.27B 1B 980M 41.83B
Net income 9.21M 11.16M 9.97M 8.35M 15.61M 1.06B 15.87M 111M 43.87M 555M 41.89M 41M 1.75B 20.27M 24.57M 21.95M 18.37M 34.37M 2.33B 34.94M 244M 96.59M 1.22B 92.23M 90.26M 3.85B
Net Debt -6.24M -7.57M -6.76M -5.66M -10.59M -718M -10.76M -75.13M -29.75M -376M -28.4M -27.8M -1.19B -23.4M -28.36M -25.33M -21.2M -39.67M -2.69B -40.32M -282M -111M -1.41B -106M -104M -4.45B
Projected Income Statement - Annual - Kuros Biosciences AG
Logo Kuros Biosciences AG
Kuros Biosciences AG is a Switzerland‑based biotechnology company engaged in the research, development, and commercialization of biologic technologies for musculoskeletal care, with a focus on those supporting bone regeneration and bone growth. The Company's key product is MagnetOs, which is a synthetic bone graft technology available in multiple formats such as granules or putty. MagnetOs is designed to stimulate bone formation, including through mechanisms that engage the body’s immune response. The technology behind MagnetOs is associated with osteoimmunology, which involves immune‑modulated bone healing. MagnetOs uses the proprietary NeedleGrip submicron surface technology, which supports bone growth by enhancing biological responses related to healing. It is indicated for use across the skeletal system and is positioned as a bone graft option for procedures involving various anatomical regions.
Employees
213
Date Price Change Volume
26-10-23 CHF 20.30 -0.29% 226,675
26-10-22 CHF 20.36 +4.73% 330,021
26-10-21 CHF 19.44 +3.79% 404,624
26-10-20 CHF 18.73 +11.16% 425,432
26-10-19 CHF 16.85 +0.30% 366,274
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Kuros Biosciences AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
20.30CHF
Average target price
34.33CHF
Spread / Average Target
+69.13%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Kuros Biosciences AG
  1. Stock Market
  2. Stocks
  3. KURN Stock